HLA DONOR SPECIFIC ANTIBODY (DSA)BY BEAD BASED IMMNUNOASSAY - LUMINEX, HEPARIN OR EDTA BLOOD

image not found

NABL Cap Accredited     
HLA Donor Specific Antibody (DSA) testing detects antibodies in a recipient’s blood that are specific to a donor’s HLA antigens. This test is critical for organ transplantation, as the presence of DSAs can increase the risk of graft rejection. It helps clinicians assess compatibility, plan immunosuppressive therapy, and monitor post-transplant antibody development. Metropolis Healthcare performs this test using advanced bead-based Luminex immunoassay technology on heparin or EDTA blood to ensure precise and reliable results

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 11,240.00

Sample Type: HEPARIN OR EDTA BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the HLA DSA test detect?
It identifies antibodies in the recipient’s blood that target donor-specific HLA antigens.

Who should undergo this test?
Transplant candidates and recipients, or individuals being evaluated for sensitization to donor antigens.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses bead-based Luminex immunoassay technology for highly sensitive and specific detection of DSAs.

What type of sample is required?
A heparinized or EDTA-anticoagulated blood sample collected via routine venipuncture.

Is fasting required for this test?
No fasting or special preparation is needed.

What does a positive result indicate?
It suggests the presence of donor-specific antibodies, which may increase the risk of graft rejection.

Can this test guide transplant decisions?
Yes, it helps clinicians evaluate transplant compatibility and plan immunosuppressive therapy.

How soon are results available from Metropolis Healthcare?

Results are generally available within 2–3 working days 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab